RCEL

Avita Therapeutics Share Price - RCEL

27.26
0.25 (0.93%)
Upgrade to Real-Time
Afterhours (Closed)
27.26
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Avita Therapeutics Inc RCEL NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.25 0.93% 27.26 17:36:11
Open Price Low Price High Price Close Price Prev Close
27.01 26.2766 27.38 27.26 27.01
Bid Price Ask Price Spread News
26.20 27.00 0.80 - -
Trades Volume VWAP Dollar Volume Avg Volume
1,784 175,455  26.90  4,720,325 148,354
Last Trade Time Type Quantity Stock Price Currency
17:11:54 50  27.10 USD

Avita Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 589.45M 21.62M 21.23M  14.26M  - -2.07 -11.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% 5.00k 0.40%

more financials information »

News Avita Therapeutics

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

RCEL Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Avita Therapeutics is a single product company, the RECELL system, an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes thus avoiding or reducing the need for skin grafts. The device is approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft tissue wounds and vitiligo underway. It is currently in roll-out across the approximately 132 burn centres in the U.S. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories. It is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly.


Your Recent History
NASDAQ
RCEL
Avita Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.